To gain insight into the recent evolution of EBOLA virus (EBOV) proteins and identify evolutionary hotspots, I investigated patterns of amino acid substitutions in the proteomes of 49 members of EBOV genus including EBOV, Bundibugyo virus (BDBV), Reston virus (RESTV), Sudan virus (SUDV) and Taï Forest virus (TAFV) spanning outbreaks from 1974 to 2014 in Democratic Republic of Congo (DRC), Uganda, Gabon, Sudan, Ivory Coast, Philippines, and Guinea among humans, non-human primates, and pigs. Of the seven genes of the Ebola genome, I found significant variations in evolutionary rates of Glycoprotein (GP), RNA/dependent RNA polymerase (L), and Nucleoprotein
Introduction:
The recent 2014 Ebola outbreak (EBOV2014) has infected more than 20,000 and claimed the life of more than 8000 people in several African countries [1] . Despite the world-wide efforts to battle the virus, it is predicted that the outbreak might not be fully contained before late 2016 [2] . EBOV has a fatality rate of 50% to 90% due to a combination of misdiagnose [3] , poor hygienic maintenance of medical facilities, and in particular the complicated multi-strategy infection mechanism of the virus [4, 5] . Whereas the first two problems must be solved by clinical measures, the latter requires molecular insight to counter EBOV adaptation to human hosts.
The negative single stranded RNA (ssRNA) genome of EBOV has seven genes that code for at least ten protein forms including glycoprotein (GP), nucleoprotein (NP), RNA-dependent RNA polymerase (L), matrix protein VP24 and VP40 [6] , transcription activator VP30 [7] , polymerase cofactor VP35 [8] , and a non-structural soluble glycoprotein, sGP [9] . At the core of the virus particles, the EBOV genome is wrapped around viral proteins NP, VP35, VP30 and L, forming a nucleocapsid structure. VP24 and VP40 bridge the nucleocapsid with an outer viral envelope flecked with GP spikes [10] , (Figure S1 in File S1). VP24 suppresses interferon production and, along with VP35 and NP, form nucleocapsid structures [11] , whereas GP spikes are essential for EBOV pathogenicity, contributing to viral attachment and fusion [12, 13] .
Early evolutionary analyses demonstrated that EBOV evolve with a rate similar to hepatitis B virus (~3.6×10 −5 nonsynonymous substitutions per site per year within the GP gene) but hundred times lower than that of retroviruses and human influenza A viruses [14] . Calculations based on whole gene sequences also estimated the rate of evolution to vary from 0.46 × 10 −4 nucleotide substitutions per site per year for Sudan EBOV to 8.21 × 10 −4 substitutions per site per year for Reston EBOV [15] .
EBOV has previously caused major outbreaks in Sudan, Democratic Republic of Congo (DRC), Republic of Congo and Gabon [16, 17] . Therefore, an important concern is the phylogenetic relation between the current 2014 outbreak and the rest of the lineages. The recent EBOV outbreak has been thought to arise from a divergent endemic variant of the Zaire EBOV lineage [18] , but the Guinea 2014 lineage was recently placed within the same Zaire EBOV lineage that caused previous outbreaks [19] . EBOV strains from patients in Sierra Leone recently revealed substitution rates roughly twice as high during outbreak as between outbreaks, and mutations were more frequently non-synonymous during outbreak [20] . Thus, outbreaks seem to provide an adaptation opportunity for the virus, and a main concern is whether EBOV evolves under adaptive or neutral evolution.
Despite previous efforts towards understanding evolution of EBOV, it is currently unknown if these changes, on the time scales of outbreaks seen so far, are caused by specific evolutionary host adaptations, as could be feared, or by random evolutionary (i.e. neutral) drift. The purpose of this work is to cast light on this question and identify the proteins, amino acids, and properties that are selected during outbreaks. With the availability of structures of some EBOV proteins, anomalously evolving residues can be structurally mapped providing valuable information for molecular-level targeting of the virus.
To answer these questions, I investigated the patterns of site-resolved evolutionary rate variation across 49 strains of EBOV, Bundibugyo virus (BDBV), Reston virus (RESTV), Sudan virus (SUDV) and Taï Forest virus (TAFV), collected from 1976 to 2014 outbreaks. I find that only three genes, NP, GP, and L, show significant rate variation across different lineages. Interestingly, GP and NP show signatures of positive selection. A branch-by-branch scan of positive selection in the evolutionary history of the virus reveals several residues under positive selection in EBOV lineages of the Philippines and Sudan outbreaks. In both GP and NP, the positively selected residues are positioned in solvent exposed regions shown previously to be antigenic. Finally, our analysis identifies adaptive changes in the chemical properties of GP and NP relevant to future prevention of Ebola adaptation to human hosts.
Results and discussion:
To evaluate the evolutionary rate (ER) of coding sequences of EBOV genes, I used the ratio of the rates of non-synonymous to synonymous substitutions (dN/dS) [21] , which measures the type and strength of selection. The evolution of a protein is potentially under positive selection when the normalized rate of nonsynonymous substitutions (dN) significantly exceeds the rate of synonymous substitutions (dS), i.e., dN/dS>1. In contrast, dN/dS <1 implies purifying selection with nonsynonymous substitutions less common than expected, compared to synonymous substitutions. When proteins evolve by random drift (neutrally), dN/dS is expected to be ~ 1.
However, whole-gene estimation of dN/dS might not fully capture the selection pressure because of variations in ER at different residues as well as branches of the phylogenetic tree. For example, positive selection (i.e., dN/dS>1) in specific residues could be masked by the presence of highly conserved (i.e., dN/dS<<1) or neutrally evolving (i.e., dN/dS<1) regions in proteins. To remove these biases, I employed different types of evolutionary analyses as explained in Methods.
I first estimated pairwise dN/dS for EBOV proteins. Since dN/dS estimation is highly sensitive to saturation of synonymous substitutions (i.e., dS > 1), I only considered comparisons in which dS < 1. As shown in Figure 1A and presented in File S1, Table S1 , the median of pairwise dN/dS are 0.25, 0.15, 0.06, 0.04, 0.05, 0.07 and 0.05 for GP, NP, L, VP24, VP30, VP35 and VP40, respectively. Thus, I find that GP and NP on average have had ~5-and ~3-fold higher rates of evolution compared to the remaining EBOV proteins.
Pairwise dN/dS may not reveal true selection on coding sequences because of averaging effects. In particular, although genes evolving with dN/dS<1 are likely under purifying selection leading to residue conservation, it is known from both real biological cases and simulations that positive selection can occur in specific sites while whole-gene dN/dS is as low as 0.25 [22, 23, 24] . I thus studied the evolution of the EBOV proteome using models that account for dN/dS variation along the branches of EBOV phylogeny or across sequences of the proteins, to identify evolutionary hotspots within the EBOV proteome.
To systematically investigate patterns of dN/dS variation in EBOV proteins, I first checked whether whole-gene dN/dS is significantly different among branches of the EBOV phylogeny ( Figure   S2 in File S1), i.e., whether the virus have evolved with different rates during different outbreaks. I compared the likelihood of one-ratio (M0) versus free-ratio (FR) models (File S1, Table S2 ). LRT is only significant for NP, GP and L genes in this comparison with p-values of 2.15×10 −7 , 2.58×10 −10 , and < 10 −15 , respectively. I then asked whether dN/dS is variable across the sequence and the functional domains of EBOV proteins are under positive selection throughout the whole phylogeny (see the explanation of M7/M8 and M8/M8fix model comparisons in File S1). From Table S3 in File S1, GP and L proteins show significant dN/dS>1 in certain residues with p-values of 2.4×10 −3 and 5.5×10 −4 , respectively (see Table S4 in File S1). However, only L protein passes the strictest criteria for positive selection (p ~ 5.5×10 −4 , see M8/M8fix model comparison in File S1 and Table S3 in File S1).
Although even the most strict site-model test only found positive selection in the L protein, real evolutionary rates more commonly change locally and rapidly for specific sites under positive selection or mutation-selection balance [25] . To identify such more realistic site-specific selection, I performed branch-site test to detect positive selection for each branch of the phylogenetic tree with no assumption of equal evolutionary rates and dN/dS allowed to vary along the branch of interest and across the sequence, as will be the case in real proteins. The likelihood of this model was compared with the null model with dN/dS = 1 and a p-value was calculated using the relevant likelihood ratio test [26] . In addition, one can compare likelihood of the null of model of branch-site test with that of M1 model. Since M1 model assumes strict neutrality, a significant likelihood difference in this comparison shows the excess of dN/dS~1 along the branch of interest which is interpreted as the sign for relaxation of functional constraints [27] . I would thus be able to distinguish between natural and relaxed evolution of EBOV proteins using this approach.
As shown in Tables S5 and S6 in File S1 and S8 in File S2, branch-site tests for positive selection revealed several residues to be under positive selection during the evolution of GP and NP ( Figure   1B I presented all residues under positive selection in GP and NP proteins in File S1, Table S6 . From the table, two interesting features become apparent: First, there is no overlap between residues detected by M7/M8 comparison (File S1, Table S4 ) and branch-site test for positive selection (File S1, Table S6 ). Therefore, GP is under weaker positive selection throughout the entire phylogeny than It is important to rule out the erroneous detection of positively selected residues because of poor alignments. For example, false detection of positively selected residues can amount to 50−55% in poorly aligned regions [30] . Therefore, I plotted residues with BEB scores > 0.5 along with residue conservation scores for the 49 EBOV GP sequences (see Methods for detail) (Figure 2A ). Sequence conservation is relatively high except for residues 312−513 where a highly variable region is observed. Positively selected residues with lower BEB scores (>0. Figure S3 in File S1). The branch-site test for positive selection explicitly detects residues with dN/dS >1 along different branches of the phylogenetic tree. Therefore, the observation of positive selection is independent of elevated dN/dS due to enhancement of substitutions with dN/dS~1 often interpreted as the sign for relaxation of functional constraints. I therefore examined the extent to which EBOV evolves under this distinct mode of evolution (Table S8 in File S2) . Surprisingly, all EBOV proteins show relaxed evolution along different branches of the phylogenetic tree. Proteins L and GP have the maximum number of branches under relaxed evolution (i.e., with 16 and 13 branches respectively). Among the outbreaks, the Philippines had the maximum number of proteins under relaxed evolution (i.e., all proteins except VP24). Significant relaxation is also observed within the outbreak of Sudan.
One possible reason for the special evolution of GP in different lineages might be the role of this protein in the first and most important step in the infection mechanism of EBOV. GP is in fact involved in attachment and membrane fusion of EBOV [12, 13] . Moreover, it has been shown that multiple immunoglobin (IgG) antibodies bind to GP epitopes, which permits binding of complement component 1R (C1) to the fragment crystalized (Fc) regions of antibodies and hence contribute to antibody-dependent infection [4] . This complex stabilizes the interaction between EBOV and its receptor, therefore enhancing the infection4. Figure 2A -B show the residues under positive selection mapped onto the crystal structure of EBOV GP and the average value of solvent accessible surface area (SASA) of these residues compared with other residues in a density plot. The majority of positively selected residues are located on the surface of GP, on average ~50% exposed to solvent and other proteins. Surprisingly, positively selected residues 217, 228, 300, 305, 307, 340, 395, and 409 with high BEB scores (Figure 2A ) are exactly within the three regions in the protein, i.e., residues 216−239, 301−359, and 381−411, that were previously shown to be immunogenic regions of EBOV GP recognized by anti-EBOV IgG [31] .
Among these, residues 217, 228, 300, 305 and 307 are within highly reliable sequence alignments and thus prime candidates for positive selection in GP epitopes. I also find positively selected residues that are adjacent in the 3D structure (residues 39 and 56 in Figure 2C and residues 142 and 217 in Figure 2D ) possibly indicating coevolution (epistasis) of conformational epitopes of GP. Figure 2E shows the crystal structure of the C-terminal domain of EBOV NP with positively selected residues mapped onto the structure. Similar to GP, residues with high BEB scores shown in Figure 2F (e.g. residues 708 and 711) tend to occur in solvent accessible regions of the protein. I also observe that positively selected residues 499 and 515 are located in previously reported reactive epitopes of NP [31] . I previously argued that the detected positive selection could be due to selection for biophysical properties or specific structural features in proteins [23, 24] , thus, I then determined if the positively selected sites in EBOV are related to specific protein properties. To this aim, I analyzed whether amino acid properties have changed significantly during the recent evolution of the EBOV proteome, using the TreeSAAP method [47] (see File S1 for details of calculations). In brief, TreeSAAP evaluates significant changes in amino acid properties during protein evolution. Since dN/dS estimation is ultimately a counting approach and does not distinguish between different types of non-synonymous substitutions, TreeSAAP complements the dN/dS analysis. Table S7 in File S1, GP, NP and L proteins again show significant selection (p < 5×10 −2 and 10 −3 ) in specific amino acid properties throughout the phylogenetic history. In particular, GP has been subject to major changes in chemical properties that are statistically significant compared to random evolution. Electrostatic properties such as polar requirements and isoelectric point, but also alpha helix propensity and hydrophobicity have changed significantly (Table S7 in File S1). These properties could relate to the function and stability of GP during host membrane interaction. NP and L also had notable properties such as polarity, hydropathy and alpha-helical tendencies changing significantly during the recent evolution of EBOV. Table S9- Figure 3A shows such a sequence-property plot for the alpha helix propensity and isoelectric point of different codons within the EBOV GP sequence. I also showed the 3D location of two peaks of this plot in the structure of EBOV GP (named as α and β clusters) in Figure 3B with sequences shown in Figures 3C and 3D , respectively. Substitutions such as Q28H, T30V, T30A and S32P increase the isoelectric point of the protein. Surprisingly, alpha helix propensity peaks at residues 75-81 (i.e., the β cluster) where a short helix is located in EBOV GP structure. Alpha helix propensity is strongly increased by substitutions such as S76A and P80L. The accelerated evolution of three proteins GP, NP and L within EBOV that I have identified may therefore relate to changes in surface interaction propensities, as most importantly seen in the case of GP, as well as structural stability of membrane fusions required for proper function of these proteins.
As summarized in
Using the dN/dS analysis, we did not observe significant positive selection in the lineage leading to 2014 EBOV species (i.e, KJ660346-348 strains in the dataset) as speculated by Gire et al [20] .
However, despite the insignificant likelihood ratio test for detection of positive selection, I observed that residue 291 has a BEB score of 0.98 consistent with a Trp to Arg mutation in the Gueckedou-C05 strain of 2014 Guinea outbreak [32] . Although such a charge-changing substitution could potentially induce functional changes, the absence of positive selection might be due to the fact that the time scale of this latest outbreak is still too short for any major adaptations to have become fixated.
Since the evolutionary rate is higher during outbreaks, prolonged outbreaks are likely to enable adaptation opportunities towards human hosts.
Our finding of positive selection of GP during the recent evolution of EBOV is in line with the recent finding that GP is the only protein that has accumulated only nonsynonymous substitutions within EBOV genomes of Sierra Leone patients 20 . In addition, Martinez et al. found a GP mutant, F88A, to facilitate entry into various human cell types [33] . Furthermore, Azizian et al. reported positive selection in the site 429 of GP [34] (corresponding to the site 431 in our sequence alignment; see File S1) also detected using M7/M8 comparison in our approach. Together with our analysis, these results establish that GP is the prime candidate for adaptation of EBOV, and the surface-centered GP properties and amino acids that I identify as adaptively changed may help in attempts to halt future adaptation of the virus to human hosts.
Methods:
I retrieved coding sequences of 49 EBOV genomes with the inferred Bayesian phylogenetic tree from the recent study of Dudas and Rambaut [19] ( Figure S2 in File S1). These sequences constitute a sampled dataset of genome sequences from the genus Ebolavirus spanning major previous outbreaks in Democratic Republic of Congo (DRC), Uganda, Gabon, Sudan, Ivory Coast, Philippines and Guinea. One could include more viral genomes from patients infected during the 2014 outbreak.
However, selection analysis, and in particular dN/dS estimation, is only accurate when the lineages are sampled in balance to avoid bias, [35] and the 49 genomes used here are thus those relevant for our purpose.
The original concatenated sequences were divided into seven protein alignment files. Protein alignments were further processed with the codon-based CLUSTAL algorithm [36] implemented in MEGA [37] . I used the ratio of the rates of nonsynonymous to synonymous substitutions (i.e., dN/dS) as a measure of selection strength as commonly applied [38] . To calculate the maximum likelihood (ML)-based dN/dS, I employed the CODEML program within the PAML suite [39] . The equilibrium codon frequencies were estimated from the products of the average observed frequencies in the threecodon positions (F3X4 model). For each of the seven EBOV genes, the tree branch lengths were first estimated with the M0 model that assumes one dN/dS across all branches and the branch length estimates were used for more advanced codon models. Ancestral sequences were inferred using the Maximum Likelihood method [40] implemented in MEGA5 [41] under the JTT model [42] as the model with highest Bayesian Information Criterion (BIC) score [43] .
Different types of dN/dS analysis were performed. First, I calculated the whole-gene dN/dS between protein sequences of any two species of interest using pairwise analysis. Second, branch models estimatd dN/dS along branches of EBOV phylogenetic tree while assuming an average ER for different residues. Third, a set of site models (i.e., M1, M2, M3, M7, M8 and M8fix models, as explained in File S1) were used to estimate dN/dS variation at different residues while taking an averaged ER of the virus along each branch of the phylogenetic tree. Eventually, a branch-site model test was employed to evaluate dN/dS for few amino acid residues along specific branches of interest in the phylogenetic tree of the virus using in house shell scripts. I employed maximum likelihood (ML) estimation of dN/dS via codon models (Material and methods). For all tested hypotheses, I compared the likelihoods of null and alternative models with likelihood ratio tests [44] . All the dN/dS estimations were performed using the CODEML package within the PAML suite [45] . Models were compared in terms of statistical significance using likelihood ratio tests [46] and posterior probabilities of residues under positive selection were identified using the Bayes Empirical Bayes (BEB) method for branch site tests of positive selection.
Selection analyses on amino acid properties were performed using the TreeSAAP approach [47] . For GP, I computed the solvent accessible surface area (SASA) from the crystal structure (PDB ID= 3CSY) [48] using the POPS algorithm [49] . Alignment conservation scores were calculated by the AMAS method [50] implemented in JALVIEW [51] which measures number of physiochemical properties conserved in each column of alignment. All codon numbers refer to alignment positions.
For a correspondence between the alignment positions referred throughout this study and the real sequences see File S1. Statistics was performed using the R package [52] and BoxPlotR web tool [53] .
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Figure 1. Evolutionary rate is higher in Glycoprotein (GP) and Nucleoprotein (NP) than other
EBOV proteins. A) Pairwise estimated dN/dS for EBOV proteins. Comparisons with dS>1 were removed to avoid synonymous saturation bias. Center lines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, and outliers are represented by dots. n = 385, 358, 364, 347, 341, 333, 352 sample points for GP, NP, L, VP24, VP30, VP35 and VP40 respectively. B) Selection criteria, twice the difference in logarithm of likelihood between alternative and null models of branch-site positive selection, versus branch number for GP (red) and NP (blue). Dashed line shows 0.05 significance level. C) Bayes Empirical Bayes score for positively selected residues (red circles) and conservation score for all residues (gray line) versus residue number in GP. Multiple sequence alignment of D) residues 34−43 and E) residues 52−61 in GP are shown with positively selected residues marked with red asterisks.
Figure 2.
Positively selected residues in EBOV Glycoprotein (GP) and Nuleoprotein (NP) are located in solvent exposed regions. A) Crystal structure of GP1 (in green) and GP2 (in cyan) subunits of EBOV GP (PDB ID= 3CSY) with positively selected residues shown in red. B) Density plot of percentage of solvent accessible surface area (%SASA) of residues within the protein to fully random coil configuration (i.e., SASAprotein/SASAcoil). Different residues such as C) His39 and Lys56 and D) Ser142 and Thr217 could potentially lie within conformational epitopes. E) Crystal structure of the C-terminal of EBOV NP (PDB ID= 4QB0) with two positively selected residues Ala708 and Glu711 shown in red. F) BEB scores of different codon positions throughout the NP sequence.
Figure 3. Ebola virus Glycoprotein shows signatures of positive selection in amino acid
properties relevant for function as well as folding stability. A) Z-score for sliding window analysis of alpha helical tendency (shown in yellow) and isoelectric point (shown in red) throughout EBOV GP sequence. Z-scores greater than 3.09 correspond to p-values < 0.001.Window size is set to 15 codons. B) α and β clusters of residues from panel A mapped onto the crystal structure of GP (PDB ID =3CSY). C) The α cluster consists of residues 28 to 33 which shows significant changes in isoelectric point. D) In β cluster, from residues 75-81, substitutions enhance alpha helical tendency.
